Movatterモバイル変換

[0]ホーム
URL:

Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Advertisement

Oncogene
  • Original Paper
  • Published:

Large-scale identification and characterization of human genes that activate NF-κB and MAPK signaling pathways

Oncogenevolume 22, pages3307–3318 (2003)Cite this article

Abstract

We have carried out a large-scale identification and characterization of human genes that activate the NF-κB and MARK signaling pathways. We constructed full-length cDNA libraries using the oligo-capping method and prepared an arrayed cDNA pool consisting of 150 000 cDNAs randomly isolated from the libraries. For analysis of the NF-κB signaling pathway, we introduced each of the cDNAs into human embryonic kidney 293 cells and examined whether it activated the transcription of a luciferase reporter gene driven by a promoter containing the consensus NF-κB binding sites. In total, we identified 299 cDNAs that activate the NF-κB pathway, and we classified them into 83 genes, including 30 characterized activator genes of the NF-κB pathway, 28 genes whose involvement in the NF-κB pathways have not been characterized and 25 novel genes. We then carried out a similar analysis for the identification of genes that activate the MARK pathway, utilizing the same cDNA resource. We assayed 145 000 cDNAs and identified 57 genes that activate the MARK pathway. Interestingly, 27 genes were overlapping between the NF-κB and the MAPK pathways, which may indicate that these genes play cross-talking roles between these two pathways.

This is a preview of subscription content,access via your institution

Access options

Access through your institution

Subscribe to this journal

Receive 50 print issues and online access

￥40,000 per year

only ￥800 per issue

Buy this article

  • Purchase on SpringerLink
  • Instant access to the full article PDF.

￥ 4,980

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 1
Figure 2

Similar content being viewed by others

References

  • Akagi T, Motegi M, Tamura A, Suzuki R, Hosokawa Y, Suzuki H, Ota H, Nakamura S, Morishima Y, Taniwaki M and Seto M . (1999).Oncogene,18, 5785–5794.

  • Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, Miller W and Lipman DJ . (1997).Nucleic Acids Res.,25, 3389–3402.

  • Baetu TM, Kwon H, Sharma S, Grandvaux N and Hiscott J . (2001).J. Immunol.,167, 3164–3173.

  • Baeuerle PA and Baltimore D . (1996).Cell,87, 13–20.

  • Baldwin Jr AS . (1996).Annu. Rev. Immunol.,14, 649–683.

  • Baldwin Jr AS . (2001).J. Clin. Invest.,107, 3–6.

  • Bannai H, Tamada Y, Maruyama O, Nakai K and Miyano S . (2001). Proceedings of the 14th International FLAIRS Conference. AAAI Press, pp. 233–238.

  • Barkett M and Gilmore T . (1999).Oncogene,18, 6910–6924.

  • Barstead R . (2001).Curr. Opin. Chem. Biol.,5, 63–66.

  • Beyaert R, Cuenda A, Vanden Berghe W, Plaisance S, Lee JC, Haegeman G, Cohen P and Fiers W . (1996).EMBO J.15, 1914–1923.

  • Dong G, Loukinova E, Chen Z, Gangi L, Chanturita TI, Liu ET and Van Waes C . (2001).Cancer Res.,61, 4797–4808.

  • Fitzgerald KA, Palsson-McDermott EM, Bowie AG, Jefferies CA, Mansell AS, Brady G, Brint E, Dunne A, Gray P, Harte MT, McMurray D, Smith DE, Sims JE, Bird TA and O'Neill LA . (2001).Nature,413, 78–83.

  • Florea L, Hartzell G, Zhang Z, Rubin GM and Miller W . (1998).Genome Res.,8, 967–974.

  • Gavin AC, Bosche M, Krause R, Grandi P, Marzioch M, Bauer A, Schultz J, Rick JM, Michon AM, Cruciat CM, Remor M, Hofert C, Schelder M, Brajenovic M, Ruffner H, Merino A, Klein K, Hudak M, Dickson D, Rudi T, Gnau V, Bauch A, Bastuck S, Huhse B, Leutwein C, Heurtier MA, Copley RR, Edelmann A, Querfurth E, Rybin V, Drewes G, Radia M, Bouwmeester T, Bork P, Seraphin B, Kuster B, Neubauer G and Superti-Furga G . (2002).Nature,415, 141–147.

  • Ghosh S, May MJ and Kopp EB . (1998).Annu. Rev. Immunol.,16, 225–260.

  • Hinz M, Loser P, Mathas S, Krappmann D, Dorken B and Scheidereit C . (2001).Blood,97, 2798–2807.

  • Ishikawa J, Kaisho T, Tomizawa H, Lee BO, Kobune Y, Inazawa J, Oritani K, Itoh M, Ochi T and Ishihara K . (1995).Genomics,26, 527–534.

  • Jacobs MD and Harrison SC . (1998).Cell,95, 749–758.

  • Joazeiro CA, Wing SS, Huang H, Leverson JD, Hunter T and Liu YC . (1999).Science,286, 309–312.

  • Joazeiro CA and Weissman AM . (2000).Cell,102, 549–552.

  • Jolliffe CN, Harvey KF, Haines BP, Parasivam G and Kumar S . (2000).Biochem. J.,351, 557–565.

  • Karin M . (1999).Oncogene,18, 6867–6874.

  • Kopp EB and Medzhitov R . (1999).Curr. Opin. Immunol.,11, 13–18.

  • Kurata H, Lee HJ, O'Garra A and Arai N . (1999).Immunity,11, 677–688.

  • Liu H, Ye H, Dogan A, Ranaldi R, Hamoudi RA, Bearzi I, Isaacson PG and Du MQ . (2001).Blood,98, 1182–1187.

  • Maruyama K and Sugano S . (1994).Gene138, 171–174.

  • Mencinger M, Panagopoulos I, Andreasson P, Lassen C, Mitelman F and Aman P . (1997).Genomics,41, 327–331.

  • Mercuric F, Zhu H, Murray BW, Shevchenko A, Bennett BL, Li J, Young DB, Barhosa M, Mann M, Manning A and Rao A . (1997).Science,278, 860–866.

  • Montaner S, Perona R, Saniger L and Lacal JC . (1998).J. Biol. Chem.,273, 12779–12785.

  • Ohtomo T, Sugamata Y, Ozaki Y, Ono K, Yoshimura Y, Kawai S, Koishihara Y, Ozaki S, Kosaka M, Hirano T and Tsuchiya, M . (1999).Biochem. Biophys. Res. Commun.,258, 583–591.

  • Pahl HL . (1999).Oncogene,18, 6853–6866.

  • Perier RC, Praz V, Junier T, Bonnard C and Bucher P . (2000).Nucleic Acids Res.,28, 302–303.

  • Reed JC . (2001).Trends. Mol. Med.,7, 314–319.

  • Sambrook J, Fritsh EF and Maniatis T . (1989).Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press: Cold Spring Harbor, NY.

    Google Scholar 

  • Schmitz ML, Bacher S and Kracht M . (2001).Trends. Biochem. Sci.,26, 186–190.

  • Schulze-Osthoff K, Ferrari D, Riehemann K and Wesselborg S . (1997).Immunobiology,198, 35–49.

  • Sedgwick SG and Smerdon SJ . (1999).Trends. Biochem. Sci.,24, 311–316.

  • Stein B, Baldwin AS Jr, Ballard DW, Greene WC, Angel P and Herrlich P . (1993).EMBO J.,12, 3879–3891.

  • Strausberg RL, Feingold EA, Klausner RD and Collins FS . (1999).Science,286, 455–457.

  • Suzuki Y, Yoshitomo K, Maruyama K, Suyama A and Sugano S . (1997).Gene,200, 149–156.

  • Suzuki Y, Taira H, Tsunoda T, Mizushima JS, Sese J, Hata H, Ota T, Isogai T, Tanaka T, Morishita S, Okubo O, Sakaki Y, Nakamura Y, Suyama A and Sugano S . (2001).EMBO Rep.,2, 388–393.

  • Uren AG, O'Rourke K, Aravind LA, Pisabarro MT, Seshagiri S, Koonin EV and Dixit VM . (2000).Mol. Cell,6, 961–967.

  • Wingender E, Chen X, Fricke E, Geffers R, Hehl R, Liebich I, Krull M, Matys V, Michael H, Ohnhauser R, Pruss M, Schacherer F, Thiele S and Urbach S . (2001).Nucleic Acids Res.,29, 281–283.

  • Verma IM and Stevenson J . (1997).Proc. Natl. Acad. Sci. USA,94, 11758–11760.

  • Xie Y and Varshavsky A . (2001).Proc. Natl. Acad. Sci. USA,98, 3056–3061.

  • Yang J, Lin Y, Guo Z, Cheng J, Huang J, Deng L, Liao W, Chen Z, Liu Z and Su B . (2001).Nat Immunol.,2, 620–624.

  • Yin MJ, Yamamoto Y and Gaynor RB . (1998).Nature,396, 77–80.

Download references

Acknowledgements

We thank K Ishizawa, M Yagi, T Sugahara, Nao Suzuki, S Suzuki, S Yoneta, Nori Suzuki and R Ooishi for their excellent screening and sequencing work. We are thankful to M Shirota and K Abe for their technical support and JM Sugano for helpful discussions. We are also grateful to E Nakajima for critical reading of the manuscript.

Author information

Authors and Affiliations

  1. Laboratory for Biology, Institute for Life Science Research, Health Care Company, ASAH1 KASEI Corporation, 2-1 Samejima, Fuji-shi, Shizuoka, 416-8501, Japan

    Akio Matsuda, Goichi Honda, Shuji Muramatsu, Osamu Matsuzaki, Yukiko Nagano & Hiroshi Hayashi

  2. Laboratory of Genome Structure Analysis, Human Genome Center, Institute of Medical Science, the University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo, 108-8639, Japan

    Akio Matsuda, Yutaka Suzuki & Sumio Sugano

  3. Department of Viral Oncology, Institute for Virus Research, Kyoto University, 53 Kawara-cho Shogo-in, Sakyo-ku, Kyoto, 606-8507, Japan

    Takahiro Doi & Kunitada Shimotohno

  4. Department of Cell and Developmental Biology, Graduate School of Biostudies, Kyoto University, Sakyo-ku, Kyoto, 606-8502, Japan

    Takeshi Harada & Eisuke Nishida

Authors
  1. Akio Matsuda
  2. Yutaka Suzuki
  3. Goichi Honda
  4. Shuji Muramatsu
  5. Osamu Matsuzaki
  6. Yukiko Nagano
  7. Takahiro Doi
  8. Kunitada Shimotohno
  9. Takeshi Harada
  10. Eisuke Nishida
  11. Hiroshi Hayashi
  12. Sumio Sugano

Corresponding author

Correspondence toAkio Matsuda.

Additional information

The nucleotide sequences reported in this paper have been deposited in the DDBJ, EMBL and Genbank database under the Accession numbers AB97000–AB97053

Supplementary information

Rights and permissions

About this article

Cite this article

Matsuda, A., Suzuki, Y., Honda, G.et al. Large-scale identification and characterization of human genes that activate NF-κB and MAPK signaling pathways.Oncogene22, 3307–3318 (2003). https://doi.org/10.1038/sj.onc.1206406

Download citation

Keywords

This article is cited by

Access through your institution
Buy or subscribe

Advertisement

Search

Advanced search

Quick links

[8]ページ先頭
©2009-2025 Movatter.jp